Clinical Trials
3 trialsNCT05054725 2026-01-06
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Phase 2 Completed
NCT06314763 2024-04-30
ROSIE
Radboud University Medical Center
Phase 4 Completed
NCT04959981 2023-07-25
HERKULES-2
Erasca, Inc.
Phase 1 Completed